Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

AeroVironment shares are trending following the company's fiscal first-quarter earnings report, which featured a revenue and earnings beat alongside a record funded backlog of $1.5 billion. While the community is debating whether the current market environment and cautious guidance justify the company's valuation, sentiment remains extremely bullish regarding the company's long-term leadership in drone and laser weapon technology.

Trump Media & Technology Group is trending as traders debate a proposed midterm stimulus promise, with significant skepticism regarding its fiscal viability and the company's financial performance. Community discussion remains highly polarized, focusing on criticisms of the proposed dividend, geopolitical tensions, and broader concerns over national debt and market stability.

Compass Pathways is trending following positive clinical developments, including a recent partnership with the U.S. Department of Veterans Affairs and successful trial results for its psilocybin treatment, COMP360. Investors are reacting to these milestones, the upcoming NDA submission, and potential FDA approval, while debating the stock's valuation relative to its industry peers.

Meta shares are trending due to the official launch of Muse, an autonomous AI personal assistant, which traders are evaluating as a potential revenue-generating catalyst for the company. Community sentiment remains divided, with supporters highlighting the product's integration across Meta's app ecosystem, while others express skepticism regarding the company's aggressive infrastructure spending and the long-term monetization of its AI initiatives.

Apple is trending as investors react to the company's annual product launch, which featured the debut of the high-end, foldable iPhone Duo alongside the iPhone 18 Pro lineup. The community is split between bullish sentiment over the hardware's potential to drive a new revenue cycle and skepticism regarding the device's high price point and late entry into the foldable market.

Traders are closely watching Oracle's upcoming earnings, with sentiment split between bullish expectations for cloud-driven growth linked to AI demand and significant concerns regarding the company's capital expenditures and debt levels. Many investors are anticipating a volatile reaction, with some positioning for a post-earnings rally while others warn of potential downside if guidance fails to reassure the market about infrastructure spending.

AbCellera is trending following strong Phase 2 data for its ABCL635 menopause drug and a subsequent oversubscribed equity offering. The community is focused on the potential for a Phase 3 trial and future partnerships, with significant enthusiasm around recent open-market insider purchases signaling management confidence.

MoonLake Immunotherapeutics is facing downward pressure following the release of Phase 3 IZAR-1 trial data, which traders and analysts describe as competitive but lacking clear superiority over existing biologics. Investor sentiment is further weighed down by the company's mixed shelf filing, which has fueled speculation about future dilution, though some long-term holders continue to emphasize the potential for best-in-class performance in hidradenitis suppurativa and the upcoming BLA submission.

Palantir is trending primarily due to the announcement of a strategic partnership with Nebius Group, which designates Nebius as a preferred sovereign AI infrastructure provider. While the community is debating this catalyst, sentiment remains divided between bulls focused on long-term AI growth and bears highlighting concerns over high valuation and persistent short-selling pressure.

MAAS is receiving significant attention as the community tracks its transition into an AI infrastructure provider, specifically focusing on its recent contract wins, development of mobile charging robotics, and strategic partnerships in the energy-compute sector. Traders are debating the company's long-term commercial execution against its history of volatility, with many watching for sustained volume and follow-through on enterprise-level deployments.